<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02035930</url>
  </required_header>
  <id_info>
    <org_study_id>TWang</org_study_id>
    <nct_id>NCT02035930</nct_id>
  </id_info>
  <brief_title>Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle</brief_title>
  <official_title>Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was done to evaluate the effects of the follicular and luteal phases of the
      menstrual cycle on sedation level at loss of consciousness and bispectral index reach to 50
      during propofol anesthesia, in patients with and without preoperative intravenous
      dexmedetomidine .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>bispectral index at loss of eyelash reflex</measure>
    <time_frame>up to 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>propofol requirements from propofol administered to loss of eyelash reflex and bispectral index reduced to 50</measure>
    <time_frame>up to 2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>duration from propofol administered to loss of eyelash reflex and bispectral index reduced to 50</measure>
    <time_frame>up to 2 years</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Abnormal Menstrual Cycle</condition>
  <arm_group>
    <arm_group_label>menstrual cycle,dexmedetomidine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <arm_group_label>menstrual cycle,dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a regular menstrual cycle

          -  elective gynecologic surgery

        Exclusion Criteria:

          -  pregnancy

          -  breastfeeding

          -  obesity

          -  known hypersensitivity to drugs used in the study protocol;

          -  use of psychotropic drugs and steroids within 72 hours before the surgery

          -  central nervous system injury

          -  renal impairment

          -  alcoholism and opioid addiction.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2014</study_first_submitted>
  <study_first_submitted_qc>January 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2014</study_first_posted>
  <last_update_submitted>January 11, 2014</last_update_submitted>
  <last_update_submitted_qc>January 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Geng guiqi</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menstruation Disturbances</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

